Lv51
960 积分 2021-06-29 加入
Efficacy of switches within the class of IL ‐17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy ( BIOREP )
3小时前
待确认
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
6天前
已完结
A Call to Action Regarding the REMS Program for Brodalumab
11天前
已完结
Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
11天前
已完结
Secondary failure of TNF-α inhibitors in clinical practice
11天前
已完结
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study
1个月前
已完结
Blocking interleukin‐17 in psoriasis: Real‐world experience from the PsoPlus cohort
1个月前
已完结
Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
1个月前
已完结
Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
1个月前
已完结
Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
